CN104366314A - Making method of mulberry health fruit lozenge - Google Patents
Making method of mulberry health fruit lozenge Download PDFInfo
- Publication number
- CN104366314A CN104366314A CN201310357246.XA CN201310357246A CN104366314A CN 104366314 A CN104366314 A CN 104366314A CN 201310357246 A CN201310357246 A CN 201310357246A CN 104366314 A CN104366314 A CN 104366314A
- Authority
- CN
- China
- Prior art keywords
- mulberry
- mulberries
- lozenge
- almond
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 50
- 240000000249 Morus alba Species 0.000 title claims abstract description 23
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 20
- 230000036541 health Effects 0.000 title claims abstract description 15
- 239000007937 lozenge Substances 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000811 xylitol Substances 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 5
- 229960002675 xylitol Drugs 0.000 claims abstract description 5
- 235000010447 xylitol Nutrition 0.000 claims abstract description 5
- 241000218231 Moraceae Species 0.000 claims description 27
- 244000144725 Amygdalus communis Species 0.000 claims description 22
- 235000020224 almond Nutrition 0.000 claims description 22
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 21
- 241000219095 Vitis Species 0.000 claims description 16
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 16
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 16
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 16
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 108010038851 tannase Proteins 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 230000032683 aging Effects 0.000 abstract description 9
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 235000006708 antioxidants Nutrition 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 6
- 239000010839 body fluid Substances 0.000 abstract description 6
- 230000003712 anti-aging effect Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000004438 eyesight Effects 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 208000003464 asthenopia Diseases 0.000 abstract description 2
- 230000036770 blood supply Effects 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 239000011707 mineral Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 244000018633 Prunus armeniaca Species 0.000 abstract 3
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 3
- 229940087559 grape seed Drugs 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 230000036039 immunity Effects 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000005189 cardiac health Effects 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- -1 oxygen radical Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a making method of a mulberry health fruit lozenge. Raw materials used in the invention mainly comprise mulberry, apricot kernel, grape seed, xylitol, maltodextrin, citric acid, magnesium stearate and Laoshan mineral water. The mulberry has the effects of skin blood supply improving, skin nourishing, skin whitening and hair blacking, and can delay aging. The mulberry can be often eaten to improve eyesight and alleviate eye fatigue and dryness, has an immunity promoting effect, and has the efficacies of liver nourishing, kidney benefiting, body fluid production promoting, intestine moistening, hair blacking and eyesight improving. The apricot kernel has very high nutritional values, is rich in unsaturated fatty acids, is beneficial to heart health, contains vitamin E and other antioxidants, and can prevent diseases and premature senility. The grape seed can eliminate free radicals, resist oxidation, enhance immunity, resist tumors and prevent cancers. No portable lozenge-like mulberry products exist in the current market. The mulberry health fruit lozenge combines anti-aging and other health effects of mulberry, the apricot kernel and the grape seed, is a green and healthy health fruit lozenge, and is suitable for all kinds of people to eat.
Description
technical fieldthe present invention relates to the preparation method of a kind of mulberry health care fruit lozenge, the raw material used is mainly mulberries, almond, grape pip, xylitol, maltodextrin, citric acid, dolomol and Laoshan Spring Water.Along with improving constantly of people's living standard, live more healthy, younger, delaying senility becomes the new pursuit of contemporary people.Therefore green health food that is anti-oxidant, function of delaying senility is had more and more to be subject to the favor of people.Mulberries are improved skin (comprising scalp) blood supply, nutrition skin, make the effects such as the delicate and Wu Fa of skin, and can delay senility.Mulberries are that the elderly is healthy and strong U.S. face, antidotal good fruit and good medicine.Normal food mulberry fruit can improving eyesight, the symptom that relieving eye strain is dry and astringent.Mulberries have immunologic enhancement.Mulberries have effect of gain to spleen, have humidification to hemolytic reaction, can prevent human body artery sclerosis, skeletal joint sclerosis, enhance metabolism.It can promote the growth of erythrocyte, prevents Neuroleptic Leukocytopenia, and has auxiliary effect to illnesss such as treatment diabetes, anaemia, hypertension, high fat of blood, coronary heart disease, neurasthenia.Mulberry fruit has promoting the production of body fluid to quench thirst, promotes digestion, helps the effects such as defecation, and proper amount of edible can promote gastric secretion, stimulates enterocinesia and removes scorching.Motherland's medical science is thought, mulberries are sweet in flavor and cold in property, there is liver-kidney tonifying, ease constipation of promoting the production of body fluid, the effect such as black invention order.The nutritive value of almond is very high.Almond contains abundant unrighted acid, is of value to health of heart; Containing polyphenoils such as vitamin Es, can prevent disease and early ageing.Grape pip can scavenging free radicals, anti-oxidant, develop immunitypty, antitumor, anti-cancer.Lack a kind of lozenge class mulberries goods that can carry with in the market.This mulberry health care fruit lozenge provided by the invention, combines the anti-ageing health-care efficacy of waiting for a long time of mulberries, almond, grape pip, can be anti-aging in advance, is a kind of health-care fruit lozenge of green health, is applicable to all kinds of crowd and eats.
background technologyaging is a kind of naturally process, and the natural-crosslinked theory of biomolecule did the elaboration of comparison system to this.This theory is pointed out when proving the molecular mechanism of Systemic aging: organism is a unstable chemical system, belongs to dissipative structure.In system, various biomolecule has a large amount of reactive groups, and they must interact and chemical reaction occurs make biomolecule slowly crosslinked to tend to chemically active stable.As time goes on, crosslinking degree constantly increases, and the reactive group of biomolecule constantly consumes minimizing, and original molecular structure changes gradually, and the accumulation Hui Shi biological tissue of these changes engenders aging phenomenon.Aging is the direct performance that function of human body slows down, and be also a kind of naturally process, over oxidation is one of old and feeble reason occurred.The harm of human body over oxidation can accelerate aging, disease, death; Cause tumour ramp; Cause inflammation, autoimmune response and make healthy wrecking; Chromogenesis precipitates, and color spot occurs.Denham Harman proposed old and feeble free radical theory in 1956, thought that the degeneration change in aging course is because the illeffects of the free radical produced in cell normal metabolic processes causes.The aging course of organism is the free radical accumulation result that the histocyte of body constantly produces, and free radical can cause DNA damage thus cause sudden change, and induced tumor is formed.Free radical is the intermediate product of eubolism, and its respond is very strong, and the many kinds of substance in cell can be made to be oxidized, infringement biomembrane.The macromolecules cross-linking such as protein, nucleic acid can also be made, affect its normal function.The evidence supporting this theory is mainly from some bodies and experiment in vitro.Compare between comprising kind, diet restriction, the oxidative pressure phenomenon relevant to age mensuration, give animal dietary antioxidant and drug-treated; Experiment in vitro mainly comprises external diploid fibroblast oxygen pressure and metabolic observation, oxygen pressure and multiplication capability and antioxidant the impact etc. of cell survival.The viewpoint of this theory can to some experimental phenomenas explained as: free radical inhibitors and antioxidant can extend the life-span of cell and animal.Interior free yl defence capability weakens with the growth at age.Vertebrate life-span length, the oxygen radical productive rate in body is low.Can be delayed senility by dietotherapy.This mulberry health care fruit lozenge provided by the invention, amino acid classes is complete, essential amino acids content is higher, be rich in various mineral matter and natural complex, have anti-ageing healthcare effect of mulberries, almond, grape pip concurrently, a kind of green Amti-sanility health-care food being applicable to all kinds of crowd and eating, easy to carry.Fill up the vacancy about lozenge class mulberries goods on market, have superior market prospects.
summary of the inventionmain points of the present invention are mulberries to clean → and grating → extracting → ferment treatment → purification → concentrate → mix with almond, grape pip powder → mixer granulation → drying → compressing tablet → sterilizing → packaging becomes a kind of mulberry health care lozenge.
The material usage that the present invention selects following (component and percentage by weight % thereof): mulberries 30.0-40.0; Almond 15.0; Grape pip 10.0; Xylitol 30.0-40.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
Mulberries 1. eat mulberries can prevent vascular sclerosis.Containing aliphatic acid in mulberry fruit, primarily of linoleic acid.Stearic acid and oleic acid composition, have and reduce fat, reduce blood fat, prevent the effects such as vascular sclerosis.2. strengthening the spleen and stomach is aid digestion.Containing nutriments such as tannic acid, aliphatic acid, malic acid in mulberry fruit, the digestion of fat, protein and starch can be helped, therefore the merit having strengthening the spleen and stomach aid digestion, can be used for treating the diarrhoea caused because of indigestion.3. supplement the nutrients.Containing a large amount of multivitamin, carrotene and trace element etc. in mulberry fruit, effectively can expand human body blood volume, be suitable for hypertension, gynaecological disease patient.4. in blacking hair and beauty mulberry fruit except the nutriment wanted containing a large amount of needed by human body, also containing Wu Fasu, hair can be made to become black and glossy, therefore can be used to beauty treatment.5. cancer-resisting.Mulberry fruit has the diffusion of prevention tumour cell to avoid cancer generation effect.Curative effect: mulberries are cold in nature to promote the production of body fluid, rock sugar is flat grows Tianjin, controls enteron aisle body fluid deficiency caused being hard and dry.
Almond dessert almond nature and flavor are sweet, pungent, and semen armeniacae amarae nature and flavor are bitter, warm.The cough-relieving of a surname's lung, depressing Qi and relieving asthma, relaxes bowel, and desinsection detoxifies.Cure mainly cough, syndrome characterized by dyspnea fullness sensation in chest, larynx numbness pharyngalgia, the dry constipation of intestines, worm carbuncle ulcer.The nutritive value of almond is very high.Almond contains abundant unrighted acid, is of value to health of heart; Containing polyphenoils such as vitamin Es, can prevent disease and early ageing.Containing protein 27%, fat 53%, carbohydrate 11% in almond, calcic 111 milligrams in every hectogram almond, 385 milligrams, phosphorus, iron 70 milligrams, also containing a certain amount of carrotene, ascorbic acid and amygdalin etc.Pass on from one to another Ming Dynasty member of Imperial Academy Xin Shixun once to go out, camp overnight in the Green City Mountain institution of Taoism, a Taoist teaches a long-lived secret recipe to him, allows him eat seven pieces of almonds every day, adheres to eating, must obtain large benefit.This member of Imperial Academy is in accordance with this side, and unremittingly, until old age, still the light body of body was strong, clear-headed and clear-sighted, resourceful, longevity does not wane.
Grape pip grape pip can scavenging free radicals, anti-oxidant; Desalination color spot, skin whitening; Keep skin elasticity, reduce wrinkle; The effect of antiallergy, anti-inflammatory; Develop immunitypty, antitumor, anti-cancer; Protective effect is had to the heart, the cerebrovascular.
Production technology of the present invention: mulberries clean → grating → extracting → ferment treatment → purification → concentrate → mix → mixer granulation → drying → compressing tablet → sterilizing → packaging with almond, grape pip powder.
The preparation method of product of the present invention is:
1) mulberries are cleaned, and first use feed grinder rough lumber, then fritter with LTP stamping machine;
2) press down squeezing at Vertical Oil press, Stress control 8.8 ~ 9.8Mpa, squeezes repeatedly, until fresh juice no longer flows out, can add water if desired and squeeze; Logical steam in thermal compressor, and with the exert pressure 5min of 74.5 ~ 102.9kPa, take out and cool, the cold water lixiviate of 26.5 DEG C, after filtration, use filtrate lixiviate again.6 times repeatedly, filtrate cools, and obtains mulberries, carrot extractive juice;
3) ferment treatment: pectase+papain+tannase+cellulase process extract;
4) purify: a small amount of cream down material of centrifugal removing;
5) almond, grape pip abrasive dust;
6) mulberries concentrate and other auxiliary materials are fully mixed by a certain percentage;
7) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
8), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
The present invention has the following advantages:
1) can delay senility, U.S. face of being healthy and strong, anti-ageing;
2) have liver-kidney tonifying, ease constipation of promoting the production of body fluid, black goal of the invention effect;
3) develop immunitypty, antitumor, anti-cancer, have protective effect to the heart, the cerebrovascular;
4) Functionality, quality and appealing design, long-term eating has no side effect.
detailed description of the invention: below in conjunction with embodiment, the present invention is described in further detail:
For 100kg product of the present invention:
1. fill a prescription: (component and percentage by weight % thereof): mulberries 30.0-40.0; Almond 15.0; Grape pip 10.0; Xylitol 30.0-40.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
2. production procedure: mulberries clean → grating → extracting → ferment treatment → purification → concentrate → mix → mixer granulation → drying → compressing tablet → sterilizing → packaging with almond, grape pip powder.
3. preparation method:
1) mulberries are cleaned, and press down squeezing at Vertical Oil press, Stress control 8.8 ~ 9.8Mpa, squeezes repeatedly, until fresh juice no longer flows out, can add water if desired and squeeze;
2) pectase+papain+tannase+cellulase process extract;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become concentrate;
5) almond, grape pip abrasive dust;
6) mulberries concentrate and other auxiliary materials are fully mixed by a certain percentage;
7) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
8), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Claims (3)
1. the present invention relates to the preparation method of a kind of mulberry health care fruit lozenge, it is characterized in that there is following formula (component and percentage by weight % thereof):
Mulberries 30.0-40.0; Almond 15.0; Grape pip 10.0; Xylitol 30.0-40.0; Maltodextrin 10.0-15.0; Citric acid 1.0; Dolomol 0.4.
2. a preparation method for mulberry health care fruit lozenge according to claim 1, is characterized in that having following production technology:
Mulberries clean → grating → extracting → ferment treatment → purification → concentrate → mix → mixer granulation → drying → compressing tablet → sterilizing → packaging with almond, grape pip powder.
3. a preparation method for a kind of mulberry health care fruit lozenge according to claim 1, is characterized in that having following preparation method:
1) mulberries are cleaned, and press down squeezing at Vertical Oil press, Stress control 8.8 ~ 9.8Mpa, squeezes repeatedly, until fresh juice no longer flows out, can add water if desired and squeeze;
2) pectase+papain+tannase+cellulase process extract;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become concentrate;
5) almond, grape pip abrasive dust;
6) mulberries concentrate and other auxiliary materials are fully mixed by a certain percentage;
7) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
8), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357246.XA CN104366314A (en) | 2013-08-16 | 2013-08-16 | Making method of mulberry health fruit lozenge |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357246.XA CN104366314A (en) | 2013-08-16 | 2013-08-16 | Making method of mulberry health fruit lozenge |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104366314A true CN104366314A (en) | 2015-02-25 |
Family
ID=52545705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310357246.XA Pending CN104366314A (en) | 2013-08-16 | 2013-08-16 | Making method of mulberry health fruit lozenge |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104366314A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106962936A (en) * | 2017-03-29 | 2017-07-21 | 山东福田药业有限公司 | A kind of mulberry enzyme slag piece and preparation method thereof |
CN108741014A (en) * | 2018-04-24 | 2018-11-06 | 北京中和鸿业医药科技有限公司 | A kind of antioxidant composition, health food, preparation method and applications |
-
2013
- 2013-08-16 CN CN201310357246.XA patent/CN104366314A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106962936A (en) * | 2017-03-29 | 2017-07-21 | 山东福田药业有限公司 | A kind of mulberry enzyme slag piece and preparation method thereof |
CN108741014A (en) * | 2018-04-24 | 2018-11-06 | 北京中和鸿业医药科技有限公司 | A kind of antioxidant composition, health food, preparation method and applications |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060277887A1 (en) | Method for processing organic plant matter into dry powder, oil and juice products | |
CN103750328A (en) | Freeze-dried compound berry superfine powder and production method thereof | |
CN105494844A (en) | Production method of Chinese wolfberry fruit tablet candy | |
CN104187679A (en) | Haematococcus pluvialis maca health product and preparation method thereof | |
CN101375727B (en) | Auricularia auricula-ginseng element beverage | |
CN102178217B (en) | Konjac-flour-containing mixture and preparation method thereof | |
CN105580952A (en) | American ginseng tableting candy production method | |
CN1292683C (en) | Solid beverage capable of balancing diet nutrition | |
CN101011073A (en) | Ginko-wheat composite powder and its producing technology | |
CN103652692A (en) | Radish leaf nutritional chewable tablet and preparation method | |
CN106213505A (en) | A kind of Moringa Haematocoocus Pluvialls tabletting health product and preparation method thereof | |
CN102578465A (en) | Composite grape skin edible mushroom healthcare fine dried noodles and making method of noodles | |
CN101129193A (en) | Compound high calcium tablet of yak medulla and method of preparing the same | |
KR102042798B1 (en) | A method for preparing functional pills comprising extracts of natural materials | |
CN105580953A (en) | Mulberry tabletting candy production method | |
KR20200023054A (en) | Powder type multiple food supplement comprising chicory extract powder, cranberry powder, green coffee extract powder, bromelain powder, acerola extract powder, ginseng extract powder and octacosanol powder | |
CN104366314A (en) | Making method of mulberry health fruit lozenge | |
CN104705630A (en) | Manufacturing method of pleurotus eryngii crystalline grains | |
KR102376726B1 (en) | Health functional pet food using deer meat and manufacturing method thereof | |
CN104366461A (en) | Manufacturing method of mulberry health fruit lozenge | |
CN104187269A (en) | Coix seed chewing tablet and preparation method thereof | |
CN103932014A (en) | Okra tea-fragrant health care rice and preparation method thereof | |
CN102783611A (en) | Manufacture process of polished round-grained rice containing rich gypenoside | |
CN102475275A (en) | Long-life medlar powder | |
CN102326655A (en) | Green healthcare longevity fruit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150225 |